Header Logo

Connection

Matthew Dysthe to Receptor, ErbB-2

Back to Details
This is a "connection" page, showing publications Matthew Dysthe has written about Receptor, ErbB-2.
Matthew Dysthe
Connection Strength
0.036
Receptor, ErbB-2
  1. Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors. Commun Biol. 2021 03 19; 4(1):368.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.